Ethnoracial Disparities Seen in Access to Genetic Testing in Pediatric Neurology
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 13, 2025 -- For pediatric neurology patients, there are marked ethnoracial disparities in genetic testing completion, according to a study published online Feb. 12 in Neurology.
Jordan Janae Cole, M.D., from the University of Colorado in Aurora, and colleagues examined whether social determinants of health (SDOH) are associated with genetic testing among pediatric neurology outpatients in a retrospective observational study using electronic health record data. Genetic testing requests, insurance denials, and test completion rates were compared for non-Hispanic single-racial or multiracial Black versus non-Hispanic single-racial White patients.
Data were included for 11,371 patients, of whom 4.9 percent completed one or more genetic test in the study interval. The researchers found that compared with Black patients, White patients were significantly more likely to have completed one or more genetic test (adjusted odds ratio, 1.88). The most common specialty through which testing was completed was outpatient pediatric neurology. There was no difference seen in neurology provider request rates for genetic testing by patient ethnoracial identity; lower insurance denial rates after neurology request were seen for White versus Black patients (relative rate ratio, 0.44); the likelihood of completing genetic testing after it was requested through neurology was lower for those with public insurance (adjusted odds ratio, 0.59). Insurance type was significantly associated only with multipanel gene completion when considering individual genetic test types (public versus private: odds ratio, 0.56).
"Recognizing ethnoracial inequities and the barriers to genetic testing due to SDOH are essential for developing interventions to eliminate testing disparities, such as improving insurance coverage and increasing availability of point-of-care genetic testing," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Odds of Advanced Cancer, Breast Cancer Death Lower in Screen-Detected Disease
THURSDAY, June 5, 2025 -- For patients aged 40 years or older, screen-detected breast cancer is associated with lower odds of advanced cancer, mastectomy, and breast...
Cardiorespiratory Effects of Smoke Fine Particulate Matter From Wildfires Can Persist for Months
THURSDAY, June 5, 2025 -- The cardiorespiratory effects of smoke fine particulate matter (PM2.5), a primary wildfire emission that can spike for months after a wildfire begins...
Experiencing Sacred Moments Is Common for Internal Medicine Doctors
THURSDAY, June 5, 2025 -- For internal medicine physicians, experiencing sacred moments (brief periods of meaningful connection between clinician and patient) is common, but...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.